Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling
about
The H19 non-coding RNA is essential for human tumor growthAtypical IκB proteins - nuclear modulators of NF-κB signalingUbiquitination regulates PTEN nuclear import and tumor suppressionThe E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammationThe deubiquitinating enzyme CYLD controls apical docking of basal bodies in ciliated epithelial cellsThe tumor suppressor CYLD regulates entry into mitosisInactivation of the CYLD deubiquitinase by HPV E6 mediates hypoxia-induced NF-kappaB activationCYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulinThe tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral responseInvolvement of the ubiquitin-like domain of TBK1/IKK-i kinases in regulation of IFN-inducible genesBRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localizationEssential role for TAX1BP1 in the termination of TNF-alpha-, IL-1- and LPS-mediated NF-kappaB and JNK signalingThe de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signalingNecroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapyRegulation of the Adaptive Immune Response by the IκB Family Protein Bcl-3NF-κB, the first quarter-century: remarkable progress and outstanding questionsPKCθ/β and CYLD are antagonistic partners in the NFκB and NFAT transactivation pathways in primary mouse CD3+ T lymphocytesLinear ubiquitination in immunityWDR20 regulates activity of the USP12 x UAF1 deubiquitinating enzyme complexA cell cycle regulatory network controlling NF-kappaB subunit activity and functionThe ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signalsNovel interactions between NFATc1 (Nuclear Factor of Activated T cells c1) and STAT-3 (Signal Transducer and Activator of Transcription-3) mediate G protein-coupled receptor agonist, thrombin-induced biphasic expression of cyclin D1, with first phasCaspase 8 inhibits programmed necrosis by processing CYLDThe tumour suppressor CYLD regulates the p53 DNA damage responseGenome-wide predictors of NF-κB recruitment and transcriptional activityRNA-Binding Protein Musashi1 Is a Central Regulator of Adhesion Pathways in Glioblastoma.The tumor promoter and NF-κB modulator Bcl-3 regulates splenic B cell development.Tumor suppressor CYLD acts as a negative regulator for non-typeable Haemophilus influenza-induced inflammation in the middle ear and lung of mice.Streptococcus pneumoniae synergizes with nontypeable Haemophilus influenzae to induce inflammation via upregulating TLR2Loss of Kindlin-1 causes skin atrophy and lethal neonatal intestinal epithelial dysfunction.Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation.Toll-like receptor-mediated down-regulation of the deubiquitinase cylindromatosis (CYLD) protects macrophages from necroptosis in wild-derived miceCytomegalovirus, Macrophages and Breast Cancer.CIRBP protects H9C2 cells against myocardial ischemia through inhibition of NF-κB pathway.Specificity of the BRISC deubiquitinating enzyme is not due to selective binding to Lys63-linked polyubiquitin.Truncation of the deubiquitinating domain of CYLD in myelomonocytic cells attenuates inflammatory responses.Oncogenic activation of NF-kappaB.Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.Serum response factor controls CYLD expression via MAPK signaling pathway.Activation of oxidative stress-regulated Bcl-3 suppresses CTCF in corneal epithelial cells.
P2860
Q21144433-276A6353-38ED-49BF-85A5-D33C5DCFD216Q21245512-559AB877-4921-4A50-80CD-A6CC55E03F75Q24292946-12C4FDCE-6E80-4183-8488-E26AB8D8EE18Q24296068-3D090C4E-027F-45C9-A15F-54F266E8A18EQ24302203-12584BE5-0FED-41E4-B729-9E506A8B129DQ24305326-4A61EDB5-C7E6-427F-9742-2D3C8D691C57Q24311308-841CF658-B4CD-4DF1-8426-F0D188C3EA01Q24314876-0410004E-8E0B-4C08-BD8E-CCB9B2E37044Q24314946-3082E6A1-9BC5-490B-A8A6-8EB2CDA82538Q24315604-CC52EA20-D5D9-4912-B60B-EB84097AD19EQ24337105-F1B8D415-1D3D-4D85-BBC5-812B00433815Q24337661-C1598C85-B410-4552-86E6-EE147511825DQ24629152-39700796-0199-4F35-9FD4-D28A84266A9CQ26739959-117B7810-D062-4AC3-BADB-1153E5EEA147Q26749588-B56FFCB8-4F2D-4E93-9ADB-0727458F78B6Q26822516-AA378121-1998-4C1F-B7AE-44EB8F347B1AQ27320965-D1BA9BA9-B950-4238-9258-741D71262DD4Q28082899-883FD986-81E5-40B6-A8F8-32907DE2407EQ28115820-8B3E4D99-FDBC-45FE-832C-4B17586CF99DQ28116296-0A01E740-3373-4882-A608-221CFC22FDE7Q28506474-5B450849-2C71-424D-A016-5342091CCFFBQ28567562-CB8E6A0A-B16E-4D76-9853-D4AED74A3CA4Q28584927-53BDE2EB-D9A1-4EBA-848E-CD520A5AC347Q28828272-3C9DDE6D-A948-4755-BA16-FD8BF79E8BDCQ30277994-121151A7-D07E-4A70-A02A-45C9641C7CEEQ30316434-8C42870F-D220-4830-A6D4-31897B5495F3Q30560173-BB8C4181-9C19-485B-82A0-4F9D9917C641Q33302126-84777E45-C12F-4FB6-865F-4CD8C6010CC3Q33355817-DEFE3CFC-BA42-4163-950E-DFFA4337B269Q33389852-9BEC9FC0-1C55-456C-9A55-972E221C3363Q33456429-7ADD187F-4834-4EFA-9D95-BD70516607A9Q33619601-2225C607-CA61-440B-9412-E24566FAD628Q33645055-2346BB5C-A712-4BFF-BDC9-D4F4410C905AQ33653392-F8056635-3D48-435A-9F17-4E7EBE4FC943Q33796008-D7D1E3A4-09F8-40AC-AB15-B87520BA1324Q33809154-09BFA957-B6F2-40F1-B758-377DE77C5929Q33849388-1D09CC1C-4DBF-4A49-9B90-BE90B5803DECQ33889168-F5F6E058-21EC-46C0-B316-DD4C4BB49FFDQ33900624-FCCFA9F8-70AC-44F0-AEB0-2881930D921AQ34017645-295E95BD-B944-4892-BB29-EF8B76CC8D59
P2860
Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling
description
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im Mai 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2006/05/19)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd op 2006/05/19)
@nl
наукова стаття, опублікована в травні 2006
@uk
مقالة علمية (نشرت في 19-5-2006)
@ar
name
Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling
@ast
Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling
@en
Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling
@nl
type
label
Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling
@ast
Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling
@en
Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling
@nl
prefLabel
Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling
@ast
Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling
@en
Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling
@nl
P2093
P921
P3181
P1433
P1476
Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling
@en
P2093
Alexander Pfeifer
Katarzyna Chmielarska
Katharina Hennecke
Ramin Massoumi
P304
P3181
P356
10.1016/J.CELL.2006.03.041
P407
P577
2006-05-19T00:00:00Z